LaVoieHealthScience Blog
O’Dwyer’s PR News: “The Biopharma Communications Balancing Act”
LaVoieHealthScience President and CEO, Donna LaVoie, contributed to the O’Dwyer’s PR News Magazine October issue focused on healthcare and medical public relations.
Environmental, Social, and Governance (ESG) Investing and the New Department of Labor (DOL) Rules
With ESG investing moving from tipping point to turning point, what impact will the new DOL rules have on investors and plan sponsors? Given the macro-level upheavals that have taken place so far in...
Mike Gaito, Global Head of Healthcare Investment Banking at J.P. Morgan talks #JPM21 going virtual, IPOs, and broader market trends for the new year
As announced last month, the 39th Annual J.P. Morgan Healthcare Conference will be held virtually from January 11-14, 2021 – a first for the conference. The bank’s decision to move to a fully virtual format has created a ripple effect among other shoulder events organized around the week of the conference, often referred to simply as “JPM Week”.
A Well-Honed Message Will Give You the Edge You Need
The SARS-CoV-2 pathogen has scrambled literally everything around the world, including financial markets and the world economy. At the same time, the biotech and pharmaceutical industries are...
Is the Potential Threat of Shareholder Activism Heightened by the Pandemic?
And is your company prepared for what may be coming next? As biotech and pharmaceutical companies work to stabilize their clinical programs and business strategies during the significant disruptions...
15 Slides to a Powerful Corporate Presentation
As a communications agency serving the biotech, pharmaceutical, and affiliated health science industry for over 20 years, LaVoieHealthScience has developed specific guidance for clients on how to...
10 JP Morgan Week Survival Tips #JPM2020
Start reaching out if you have not already to top targetsSpread a wide net. Extend your reach and target 20% or more new names. 2x outreach + personal emails. Master schedule, one pen....
What Life Science Innovators Need to Know About MiFID II for Capital Access and Research Coverage
The EU’s signature framework for the financial markets is starting to have major impacts in the US What are the challenges and potential opportunities for companies in the life sciences? On January...
How Your Company’s LinkedIn Presence Extends Your Brand Beyond Other Social Media
LinkedIn is a critical tool for networking, branding, and showcasing the talent that makes your team unique. With a growing number of life science professionals on LinkedIn, your company’s presence...
Communications Strategies to Prepare for an IPO, and Beyond
How you tell your company’s story before, during and after an IPO can have a big impact on your valuation and market success Preparing for an IPO signs you and your company up for months of hard...